Blue Crest Capital Management LTD Pfizer Inc Put Options Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $3.11 Million - $3.57 Million	-120,000 Reduced 49.55%	122,200 $3.39 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $2.87 Million - $3.73 Million	109,800 Added 82.93%	242,200 $6.97 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $1.88 Million - $2.2 Million	-58,700 Reduced 30.72%	132,400 $4.39 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $6.9 Million - $7.99 Million	191,100 New	191,100 $7.01 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.